Elevated serum chromogranin A in patients with hepatocellular carcinoma

Clinical and Experimental Medicine

Volumn 2, Issue 3, 2002, Pages 119-123

  Leone, Nic ^a   Pellicano, R ^a   Brunello, F ^a   Rizzetto, M ^a   Ponzetto, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Alpha fetoprotein; Chromogranin A; Endocrine tumors; Hepatocellular carcinoma; Liver cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; CELL MARKER; CHROMOGRANIN A; CHROMOGRANIN; CHROMOGRANIN A, HUMAN; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM; FEMALE; HEMOCHROMATOSIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNORADIOMETRIC ASSAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; BLOOD; CELL DIFFERENTIATION; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036452289     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380200016     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29
2. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
3. Taylor-Robinson SD, Foster GR, Arora S et al (1997) Increase in primary liver cancer in the UK, 1974-94. Lancet 350:1142-1143
4. Colombo M, De Franchis R, Del Ninno E et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325:675-690
5. Yano M, Kumada H, Kage M et al (1996) The long term pathological evolution of chronic hepatitis C. Hepatology 23:1334-1340
6. Chiaramonte M, Stroffolini T, Vian A et al (1999) Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 85:2132-2137
7. Sato Y, Nakata K, Kato Y et al (1993) Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 328:1802-1806
8. Weitz IC, Liebman HA (1993) Des-g-carboxy (abnormal) pro-thrombin and hepatocellular carcinoma: A critical review. Hepatology 18:990-997
9. Trojan J, Raedle J, Zeuzem S (1998) Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment. Digestion 59:72-74
10. Iacangelo A, Affolter HU, Eiden LE et al (1986) Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 323:82-86
11. Norgaard T, Bardram L (1985) Endocrine liver tumor differential diagnosis from hepatocellular carcinoma. Histopatology 9:777-781
12. Tajima Y, Nakajima T, Sugano I et al (1992) Hepatocellular carcinoma containing endocrine cells. An autopsy report of triple cancer involving the liver, kidney and thyroid. Acta Pathol Jpn 42:904-910
13. Roskams T, Willems M, Campos RV et al (1993) Parathyroid hormone-related peptide expression in primary and metastatic liver tumours. Histopathology 23:519-525
14. Nakajima K, Sakurai A, Katai M et al (2000) Chromogranin A expression in hepatocellular carcinoma in a patient with germ line MEN 1 gene mutation. Intern Med 39:20-24
15. Pugh RNH, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding esophageal varices. Br J Surg 60:646-649
16. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7:462-503
17. Kimura N, Miura W, Noshiro T et al (1997) Plasma chromo-granin A in pheochromocytoma, primary hyperparathy-roidism and pituitary adenoma in comparison with cate-cholamine, parathyroid hormone and pituitary hormones. Endocr J 44:319-327
18. Stridsberg M, Husebye ES (1997) Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytoma. Eur J Endocrinol 136:67-73
19. Di Sant'Agnese PA, Mesy Jensen KL de (1987) Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 18:849-856
20. Di Sant'Agnese PA, Cockett ATK (1996) Neuroendocrine differentiation in prostatic malignancy. Cancer 78:357-361
21. Theodorescu D, Broder SR, Boyd JC et al (1997) Cathepsin D and chromogranin A as predictor of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 80:2109-2119
22. Kadmon D, Thompson TC, Lynch GR et al (1991) Elevated plasma chromogranin A concentrations in prostatic carcinoma. J Urol 146:358-361
23. Bosman FT (1997) Neuroendocrine cells in non-endocrine tumors: What does it mean? Verh Dtsch Ges Path 81:62-72
24. Zhao M, Laissue JA, Zimmermann A (1993) Neuroendocrine differentiation in hepatocellular carcinomas (HCCs): Immunohistochemical reactivity is related to distinct tumor cell types, but not tumor grade. Histol Histopathol 8:617-626
25. Libbrecht L, Desmet V, Van Damme B et al (2000) The immunohistochemical phenotype of dysplastic foci in human liver: Correlation with putative progenitor cells. J Hepatol 33:76-84
26. Lowes KN, Brennan BA, Yeoh GC et al (1999) Oval cell numbers in human chronic liver disease are directly related to disease severity. Am J Pathol 154:537-541
27. Su Q, Liu YF, Zhang JF et al (1994) Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression. Hepatology 20:788-799
28. Hsia CC, Thorgeirsson SS, Tabor E (1994) Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol 43:216-221
29. Hsia CC, Evarts RP, Nakatsukasa H et al (1992) Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 16:1327-1333
30. Deftos LJ (1991) Chromogranin A: Its role in endocrine and neuroendocrine tumor marker. Endocr Rev 12:181-287